UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by LGT Fund Management Co Ltd.

Key Points

• LGT Fund Management Co Ltd. increased its stake in UnitedHealth Group by 13.3%, adding 4,838 shares, bringing its total holdings to 41,189 shares worth approximately $21.57 million.
• Several hedge funds, including GAMMA Investing LLC and Vanguard Group Inc., have also significantly adjusted their positions in UnitedHealth Group during the first quarter.
• Analysts have been revising their ratings and price targets for UnitedHealth Group, with three issuing sell ratings, seven giving hold ratings, and fifteen assigning buy ratings, leading to an average target price of $366.52.

LGT Fund Management Co Ltd. increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,189 shares of the healthcare conglomerate's stock after acquiring an additional 4,838 shares during the period. UnitedHealth Group comprises about 1.9% of LGT Fund Management Co Ltd.'s holdings, making the stock its 10th largest holding. LGT Fund Management Co Ltd.'s holdings in UnitedHealth Group were worth $21,573,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Clal Insurance Enterprises Holdings Ltd grew its position in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Resona Asset Management Co. Ltd. increased its position in UnitedHealth Group by 7.1% during the first quarter. Resona Asset Management Co. Ltd. now owns 304,422 shares of the healthcare conglomerate's stock worth $159,104,000 after buying an additional 20,241 shares during the last quarter. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new stake in shares of UnitedHealth Group in the first quarter worth about $733,000. Tlwm increased its holdings in shares of UnitedHealth Group by 1.0% during the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate's stock valued at $1,433,000 after acquiring an additional 28 shares during the last quarter. Finally, Bulltick Wealth Management LLC boosted its position in UnitedHealth Group by 152.0% during the first quarter. Bulltick Wealth Management LLC now owns 7,960 shares of the healthcare conglomerate's stock worth $4,169,000 after purchasing an additional 4,801 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other news, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kristen Gil bought 3,700 shares of the company's stock in a transaction dated Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director owned 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. 0.28% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. Wolfe Research decreased their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Royal Bank Of Canada dropped their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. HSBC reaffirmed a "reduce" rating and issued a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Piper Sandler dropped their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Finally, Morgan Stanley decreased their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $366.52.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $9.22 on Tuesday, hitting $261.59. The stock had a trading volume of 12,160,581 shares, compared to its average volume of 18,478,328. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a market capitalization of $237.30 billion, a price-to-earnings ratio of 11.33, a price-to-earnings-growth ratio of 1.63 and a beta of 0.43. The firm's 50 day moving average price is $289.94 and its 200-day moving average price is $402.24. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business posted $6.80 EPS. The business's quarterly revenue was up 12.9% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.4%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.